ELEKTA B SHS UNSP/ADR (EKTAY) Stock Price, Quote & AI Analysis
Live EKTAY stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for ELEKTA B SHS UNSP/ADR.
TradeVae provides AI-driven analysis and real-time market intelligence for ELEKTA B SHS UNSP/ADR (EKTAY), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
ELEKTA B SHS UNSP/ADR's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
ELEKTA B SHS UNSP/ADR Overview
Company information
Company Overview
Elekta AB is a medical technology company, which engages in the provision of clinical solutions for the treatment of cancers and brain disorders. The firm's products and solutions include radiotherapy, stereotactic radiosurgery, oncology informatics, brachytheraphy, neurosurgery, and particle therapy. It operates through the following geographical segments: Americas, EMEA, APAC, and Others. The company was founded by Lars Leksell and Laurent Leksell in 1972 and is headquartered in Stockholm, Sweden. EKTAY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
ELEKTA B SHS UNSP/ADR Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...